The Evolution of HTA in Emerging Markets Health-Care ... - TREE
The Evolution of HTA in Emerging Markets Health-Care ... - TREE
The Evolution of HTA in Emerging Markets Health-Care ... - TREE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
OHE Consult<strong>in</strong>g Report for PhRMA<br />
5 January 2011<br />
<strong>in</strong>terpretation <strong>of</strong> values and traditions, and views from stakeholders. <strong>HTA</strong> is def<strong>in</strong>ed as systematic<br />
knowledge that fills the gap between scientific knowledge and decision-‐mak<strong>in</strong>g; <strong>HTA</strong> is a tool for<br />
knowledge management and an aid to decision-‐mak<strong>in</strong>g.<br />
<strong>The</strong> paper argues that <strong>HTA</strong> needs to be developed further (<strong>in</strong> response to demand for <strong>in</strong>formation<br />
by decision-‐makers) <strong>in</strong> two areas: the underly<strong>in</strong>g methodological approach, and extension <strong>of</strong> <strong>HTA</strong> to<br />
assessment <strong>of</strong> other health technologies besides healthcare products. So far <strong>HTA</strong> has been almost<br />
exclusively applied to decisions regard<strong>in</strong>g availability and reimbursement <strong>of</strong> healthcare products and<br />
services. It is better, the paper argues, to extend <strong>HTA</strong> to cover other health technologies (as they are<br />
also <strong>in</strong>puts for healthcare and health production). Figure 6 below shows the current focus on <strong>HTA</strong><br />
and its possible extension to other two types <strong>of</strong> health technologies.<br />
Figure 6: <strong>HTA</strong> with<strong>in</strong> the healthcare system: current application to coverage decisions (A) and<br />
proposed expansion <strong>of</strong> <strong>HTA</strong> role (B and C): Garrido et al (2010)<br />
By assess<strong>in</strong>g the cl<strong>in</strong>ical and economic value <strong>of</strong> the three types <strong>of</strong> health technologies, <strong>HTA</strong> can<br />
contribute to achiev<strong>in</strong>g ‘community effectiveness’ (<strong>in</strong> rout<strong>in</strong>e cl<strong>in</strong>ical practice) that is as close as<br />
possible to efficacy levels measured <strong>in</strong> controlled cl<strong>in</strong>ical trial sett<strong>in</strong>gs. <strong>The</strong> paper concludes by<br />
suggest<strong>in</strong>g that countries embark<strong>in</strong>g on <strong>HTA</strong> (<strong>in</strong>clud<strong>in</strong>g low-‐ and middle-‐<strong>in</strong>come countries) should<br />
not consider establish<strong>in</strong>g completely separate agencies for <strong>HTA</strong>, quality development, performance<br />
measurement and health services development; but rather comb<strong>in</strong>e these agencies <strong>in</strong>to a common<br />
knowledge or evidence synthesis strategy for evidence-‐<strong>in</strong>formed decision-‐mak<strong>in</strong>g.<br />
37